[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report Forecast 2017-2021

March 2017 | 116 pages | ID: G3592F424C2EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
  • United States
  • China
  • Europe
  • Japan
The Major players reported in the market include:
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc
Geri-Care Pharmaceuticals
Perrigo Company
Kopran Ltd.
Merck Sharp & Dohme Corp.
Sun Pharmaceutical Industries Ltd
Product Segment Analysis:
Type 1
Type 2
Type 3
Application Segment Analysis:
Application 1
Application 2
Application 3

REASONS FOR BUYING THIS REPORT
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified analysis of major market segments
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report Forecast 2017-2021

1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET OVERVIEW

1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Non-steroidal Anti-inflammatory Drugs (NSAID)
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Non-steroidal Anti-inflammatory Drugs (NSAID) (2012-2021)
  1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2021)
  1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MANUFACTURING COST ANALYSIS

3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
  5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufacturers (2012-2017)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Type
  5.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2012-2017)
  5.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Regions
  5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Regions (2012-2017)
5.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume) by Application

6 UNITED STATES NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) (VOLUME, VALUE AND SALES PRICE)

6.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
  6.1.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
  6.1.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
  6.1.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
6.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
6.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
6.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

7 CHINA NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) (VOLUME, VALUE AND SALES PRICE)

7.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
  7.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
  7.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
  7.1.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
7.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
7.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
7.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

8 EUROPE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
  8.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
  8.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
8.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

9 JAPAN NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
  9.1.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
  9.1.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
9.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
9.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
9.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

10 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MANUFACTURERS ANALYSIS

10.1 Bayer (DE)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Novacap (FR)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Abbott
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Pfizer Inc
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Geri-Care Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Perrigo Company
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Kopran Ltd.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Merck Sharp & Dohme Corp.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Sun Pharmaceutical Industries Ltd
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET FORECAST (2017-2021)

13.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue Forecast (2017-2021)
13.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions (2017-2021)
13.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2017-2021)
13.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2017-2021)

14 APPENDIX
LIST OF TABLES AND FIGURES

Figure Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015
Table Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2015
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales of Key Manufacturers (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2012-2017)
Figure 2015 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Type (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Type (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Regions (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Regions (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Regions (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2012-2017)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2012-2017)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2012-2017)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2012-2017)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2012-2017)
Table Bayer (DE) Basic Information List
Table Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Novacap (FR) Basic Information List
Table Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Geri-Care Pharmaceuticals Basic Information List
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Perrigo Company Basic Information List
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Kopran Ltd. Basic Information List
Table Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Merck Sharp & Dohme Corp. Basic Information List
Table Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Sun Pharmaceutical Industries Ltd Basic Information List
Table Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
Table Major Buyers of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Distributors/Traders List
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate Forecast (2017-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate Forecast (2017-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions (2017-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2017-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2017-2021)


More Publications